One year in review; Authors: Alessandra Bortoluzzi, Federica Furini, Elena Generali, Ettore Silvagni, Nicoletta Luciano, Carlo Alberto Scirè
clinexprheumatol.org
Mavrilimumab well tolerated among patients with RA
Mavrilimumab treatment for more than 3 years maintained response and…
healio.com
Since the introduction of TNF-α inhibitors and other biologic agents, the clinical outcome for many treated rheumatoid arthritis patients has signific…
sciencedirect.com
nature.com